INCY
HealthcareIncyte Corporation
$92.25+0.24 (+0.27%)
Prev Close
$92.03
Open
$93.25
High
$93.64
Low
$91.28
Volume
1.05M
Market Cap
$20.10B
P/E
16.80
Div Yield
—
Over the past 12 months, insider activity at Incyte Corporation (INCY) has been exclusively selling, with 0 insider purchases totaling $0.00 and 55 insider sales totaling $57.16M. The most recent insider transaction was by CAGNONI PABLO J (officer: President, R&D), who sold $1.88M worth of shares on Feb 23, 2026. Incyte Corporation operates in the Healthcare sector, within the Biotechnology industry, with a market cap of $20.10B.
Buys (12M)
0
$0.00
Sells (12M)
55
$57.16M
Net Activity
Net Seller
$57.16M
Active Insiders
15
last 12 mo
INCY Price Chart
INCY Insider Trading Activity
| Date | Insider | Role | Type | Shares | Avg Price | Value | Shares After |
|---|---|---|---|---|---|---|---|
| Feb 23, 2026↗ | CAGNONI PABLO J | officer: President, R&D | Sell | 18,668 | $100.91 | $1.88M | 234,800 |
| Feb 19, 2026↗ | CAGNONI PABLO J | President, R&D | Sell | 18,668 | $100.91 | $1.88M | 0 |
| Feb 4, 2026↗ | Heeson Lee | EVP, Head of Incyte Intl | Sell | 111 | $102.67 | $11.4K | 0 |
| Feb 4, 2026↗ | Morrissey Michael James | EVP, Head of Tech. Operations | Sell | 185 | $102.67 | $19.0K | 0 |
| Jan 21, 2026↗ | Morrissey Michael James | EVP, Head of Tech. Operations | Sell | 429 | $102.62 | $44.0K | 0 |
| Jan 8, 2026↗ | Issa Mohamed Khairie | officer: EVP, Head of US Oncology | Sell | 29,976 | $108.41 | $3.25M | 66,132 |
| Jan 7, 2026↗ | Stein Steven H | officer: EVP & Chief Medical Officer | Sell | 31,268 | $101.70 | $3.18M | 34,203 |
| Jan 5, 2026↗ | Morrissey Michael James | EVP, Head of Tech. Operations | Sell | 254 | $98.77 | $25.1K | 0 |
| Jan 5, 2026↗ | Stein Steven H | EVP & Chief Medical Officer | Sell | 13,292 | $98.77 | $1.31M | 0 |
| Dec 22, 2025↗ | Tray Thomas | Principal Accounting Officer | Sell | 3,374 | $99.69 | $336.4K | 0 |
| Dec 18, 2025↗ | Morrissey Michael James | EVP, Head of Tech. Operations | Sell | 58,331 | $97.29 | $5.67M | 0 |
| Dec 12, 2025↗ | Mayes Patrick A | EVP & Chief Scientific Officer | Sell | 5,808 | $95.55 | $555.0K | 0 |
| Dec 10, 2025↗ | Hoppenot Herve | Director | Sell | 2,843 | $96.70 | $274.9K | 0 |
| Dec 3, 2025↗ | Morrissey Michael James | EVP, Head of Tech. Operations | Sell | 326 | $102.04 | $33.3K | 0 |
| Dec 3, 2025↗ | Stein Steven H | EVP & Chief Medical Officer | Sell | 39,757 | $102.34 | $4.07M | 0 |
| Nov 25, 2025↗ | Tray Thomas | Principal Accounting Officer | Sell | 769 | $102.78 | $79.0K | 0 |
| Nov 19, 2025↗ | Denton Sheila A. | EVP & General Counsel | Sell | 278 | $104.36 | $29.0K | 0 |
| Nov 12, 2025↗ | Hoppenot Herve | Director | Sell | 187,500 | $105.46 | $19.77M | 0 |
| Nov 7, 2025↗ | Stein Steven H | EVP & Chief Medical Officer | Sell | 5,233 | $102.20 | $534.8K | 0 |
| Nov 6, 2025↗ | Denton Sheila A. | EVP & General Counsel | Sell | 598 | $101.36 | $60.6K | 0 |
| Nov 5, 2025↗ | Heeson Lee | EVP, Head of Incyte Intl | Sell | 3,074 | $94.02 | $289.0K | 0 |
| Oct 17, 2025↗ | Denton Sheila A. | EVP & General Counsel | Sell | 277 | $85.13 | $23.6K | 0 |
| Oct 6, 2025↗ | Denton Sheila A. | EVP & General Counsel | Sell | 7,230 | $86.04 | $622.0K | 0 |
| Oct 3, 2025↗ | Heeson Lee | EVP, Head of Incyte Intl | Sell | 463 | $86.70 | $40.1K | 0 |
| Oct 3, 2025↗ | Mayes Patrick A | EVP & Chief Scientific Officer | Sell | 1,569 | $86.70 | $136.0K | 0 |
| Sep 18, 2025↗ | Denton Sheila A. | EVP & General Counsel | Sell | 278 | $83.15 | $23.1K | 0 |
| Sep 4, 2025↗ | Denton Sheila A. | EVP & General Counsel | Sell | 598 | $84.97 | $50.8K | 0 |
| Aug 19, 2025↗ | Denton Sheila A. | EVP & General Counsel | Sell | 277 | $86.81 | $24.0K | 0 |
| Aug 6, 2025↗ | Denton Sheila A. | EVP & General Counsel | Sell | 598 | $75.77 | $45.3K | 0 |
| Jul 23, 2025↗ | Stein Steven H | EVP & Chief Medical Officer | Sell | 3,706 | $67.94 | $251.8K | 0 |
| Jul 17, 2025↗ | Denton Sheila A. | EVP & General Counsel | Sell | 4,818 | $69.38 | $334.3K | 0 |
| Jul 17, 2025↗ | Flannelly Barry P | EVP & General Manager US | Sell | 1,340 | $68.36 | $91.6K | 0 |
| Jul 17, 2025↗ | Iyengar Vijay K | EVP, GMAPPS | Sell | 983 | $68.36 | $67.2K | 0 |
| Jul 17, 2025↗ | Trotta Matteo | EVP, GM, Dermatology US | Sell | 182 | $68.25 | $12.4K | 0 |
| Jul 16, 2025↗ | CAGNONI PABLO J | President, R&D | Sell | 3,908 | $68.82 | $268.9K | 0 |
| Jul 16, 2025↗ | Flannelly Barry P | EVP & General Manager US | Sell | 3,255 | $69.33 | $225.7K | 0 |
| Jul 16, 2025↗ | Hoppenot Herve | Special Advisor to the CEO | Sell | 9,674 | $69.14 | $668.8K | 0 |
| Jul 16, 2025↗ | Iyengar Vijay K | EVP, GMAPPS | Sell | 2,608 | $69.37 | $180.9K | 0 |
| Jul 16, 2025↗ | Stamoulis Christiana | EVP & Chief Financial Officer | Sell | 2,852 | $69.10 | $197.1K | 0 |
| Jul 16, 2025↗ | Stein Steven H | EVP & Chief Medical Officer | Sell | 18,103 | $68.58 | $1.24M | 0 |
| Jul 16, 2025↗ | SWAIN PAULA J | EVP, Human Resources | Sell | 1,007 | $69.01 | $69.5K | 0 |
| Jul 16, 2025↗ | Tray Thomas | Principal Accounting Officer | Sell | 1,275 | $69.19 | $88.2K | 0 |
| Jul 7, 2025↗ | Denton Sheila A. | EVP & General Counsel | Sell | 599 | $68.61 | $41.1K | 0 |
| Jul 7, 2025↗ | Flannelly Barry P | EVP & General Manager US | Sell | 19,958 | $68.16 | $1.36M | 0 |
| Jul 7, 2025↗ | Hoppenot Herve | Special Advisor to the CEO | Sell | 42,769 | $68.17 | $2.92M | 0 |
| Jul 7, 2025↗ | Iyengar Vijay K | EVP, GMAPPS | Sell | 15,426 | $68.16 | $1.05M | 0 |
| Jul 7, 2025↗ | Stamoulis Christiana | EVP & Chief Financial Officer | Sell | 11,589 | $68.17 | $790.0K | 0 |
| Jul 7, 2025↗ | Stein Steven H | EVP & Chief Medical Officer | Sell | 12,714 | $68.17 | $866.7K | 0 |
| Jul 7, 2025↗ | SWAIN PAULA J | EVP, Human Resources | Sell | 6,285 | $68.17 | $428.4K | 0 |
| Jul 7, 2025↗ | Tray Thomas | Principal Accounting Officer | Sell | 897 | $68.17 | $61.1K | 0 |
| Jun 12, 2025↗ | Schaffert Susanne | Director | Sell | 849 | $70.07 | $59.5K | 0 |
| Jun 5, 2025↗ | Denton Sheila A. | EVP & General Counsel | Sell | 1,795 | $68.00 | $122.1K | 0 |
| Jun 3, 2025↗ | Tray Thomas | Principal Accounting Officer | Sell | 1,614 | $65.38 | $105.5K | 0 |
| Mar 27, 2025↗ | Trotta Matteo | EVP, GM, Dermatology US | Sell | 537 | $62.08 | $33.3K | 0 |
| Mar 18, 2025↗ | Flannelly Barry P | EVP & General Manager US | Sell | 19,807 | $67.69 | $1.34M | 0 |
| Mar 6, 2025↗ | Denton Sheila A. | EVP & General Counsel | Sell | 599 | $69.99 | $41.9K | 0 |
| Feb 28, 2025↗ | Denton Sheila A. | EVP & General Counsel | Sell | 14,069 | $74.07 | $1.04M | 0 |
INCY Insider Buying Activity
The following table shows recent insider purchases of Incyte Corporation (INCY) stock reported via SEC Form 4 filings.
No insider buying activity found for INCY in the last 12 months.
INCY Insider Selling Activity
The following table shows recent insider sales of Incyte Corporation (INCY) stock reported via SEC Form 4 filings.
| Date | Insider | Role | Type | Shares | Avg Price | Value | Shares After |
|---|---|---|---|---|---|---|---|
| Feb 23, 2026↗ | CAGNONI PABLO J | officer: President, R&D | Sell | 18,668 | $100.91 | $1.88M | 234,800 |
| Feb 19, 2026↗ | CAGNONI PABLO J | President, R&D | Sell | 18,668 | $100.91 | $1.88M | 0 |
| Feb 4, 2026↗ | Heeson Lee | EVP, Head of Incyte Intl | Sell | 111 | $102.67 | $11.4K | 0 |
| Feb 4, 2026↗ | Morrissey Michael James | EVP, Head of Tech. Operations | Sell | 185 | $102.67 | $19.0K | 0 |
| Jan 21, 2026↗ | Morrissey Michael James | EVP, Head of Tech. Operations | Sell | 429 | $102.62 | $44.0K | 0 |
| Jan 8, 2026↗ | Issa Mohamed Khairie | officer: EVP, Head of US Oncology | Sell | 29,976 | $108.41 | $3.25M | 66,132 |
| Jan 7, 2026↗ | Stein Steven H | officer: EVP & Chief Medical Officer | Sell | 31,268 | $101.70 | $3.18M | 34,203 |
| Jan 5, 2026↗ | Morrissey Michael James | EVP, Head of Tech. Operations | Sell | 254 | $98.77 | $25.1K | 0 |
| Jan 5, 2026↗ | Stein Steven H | EVP & Chief Medical Officer | Sell | 13,292 | $98.77 | $1.31M | 0 |
| Dec 22, 2025↗ | Tray Thomas | Principal Accounting Officer | Sell | 3,374 | $99.69 | $336.4K | 0 |
| Dec 18, 2025↗ | Morrissey Michael James | EVP, Head of Tech. Operations | Sell | 58,331 | $97.29 | $5.67M | 0 |
| Dec 12, 2025↗ | Mayes Patrick A | EVP & Chief Scientific Officer | Sell | 5,808 | $95.55 | $555.0K | 0 |
| Dec 10, 2025↗ | Hoppenot Herve | Director | Sell | 2,843 | $96.70 | $274.9K | 0 |
| Dec 3, 2025↗ | Morrissey Michael James | EVP, Head of Tech. Operations | Sell | 326 | $102.04 | $33.3K | 0 |
| Dec 3, 2025↗ | Stein Steven H | EVP & Chief Medical Officer | Sell | 39,757 | $102.34 | $4.07M | 0 |
| Nov 25, 2025↗ | Tray Thomas | Principal Accounting Officer | Sell | 769 | $102.78 | $79.0K | 0 |
| Nov 19, 2025↗ | Denton Sheila A. | EVP & General Counsel | Sell | 278 | $104.36 | $29.0K | 0 |
| Nov 12, 2025↗ | Hoppenot Herve | Director | Sell | 187,500 | $105.46 | $19.77M | 0 |
| Nov 7, 2025↗ | Stein Steven H | EVP & Chief Medical Officer | Sell | 5,233 | $102.20 | $534.8K | 0 |
| Nov 6, 2025↗ | Denton Sheila A. | EVP & General Counsel | Sell | 598 | $101.36 | $60.6K | 0 |
| Nov 5, 2025↗ | Heeson Lee | EVP, Head of Incyte Intl | Sell | 3,074 | $94.02 | $289.0K | 0 |
| Oct 17, 2025↗ | Denton Sheila A. | EVP & General Counsel | Sell | 277 | $85.13 | $23.6K | 0 |
| Oct 6, 2025↗ | Denton Sheila A. | EVP & General Counsel | Sell | 7,230 | $86.04 | $622.0K | 0 |
| Oct 3, 2025↗ | Heeson Lee | EVP, Head of Incyte Intl | Sell | 463 | $86.70 | $40.1K | 0 |
| Oct 3, 2025↗ | Mayes Patrick A | EVP & Chief Scientific Officer | Sell | 1,569 | $86.70 | $136.0K | 0 |
| Sep 18, 2025↗ | Denton Sheila A. | EVP & General Counsel | Sell | 278 | $83.15 | $23.1K | 0 |
| Sep 4, 2025↗ | Denton Sheila A. | EVP & General Counsel | Sell | 598 | $84.97 | $50.8K | 0 |
| Aug 19, 2025↗ | Denton Sheila A. | EVP & General Counsel | Sell | 277 | $86.81 | $24.0K | 0 |
| Aug 6, 2025↗ | Denton Sheila A. | EVP & General Counsel | Sell | 598 | $75.77 | $45.3K | 0 |
| Jul 23, 2025↗ | Stein Steven H | EVP & Chief Medical Officer | Sell | 3,706 | $67.94 | $251.8K | 0 |
| Jul 17, 2025↗ | Denton Sheila A. | EVP & General Counsel | Sell | 4,818 | $69.38 | $334.3K | 0 |
| Jul 17, 2025↗ | Flannelly Barry P | EVP & General Manager US | Sell | 1,340 | $68.36 | $91.6K | 0 |
| Jul 17, 2025↗ | Iyengar Vijay K | EVP, GMAPPS | Sell | 983 | $68.36 | $67.2K | 0 |
| Jul 17, 2025↗ | Trotta Matteo | EVP, GM, Dermatology US | Sell | 182 | $68.25 | $12.4K | 0 |
| Jul 16, 2025↗ | CAGNONI PABLO J | President, R&D | Sell | 3,908 | $68.82 | $268.9K | 0 |
| Jul 16, 2025↗ | Flannelly Barry P | EVP & General Manager US | Sell | 3,255 | $69.33 | $225.7K | 0 |
| Jul 16, 2025↗ | Hoppenot Herve | Special Advisor to the CEO | Sell | 9,674 | $69.14 | $668.8K | 0 |
| Jul 16, 2025↗ | Iyengar Vijay K | EVP, GMAPPS | Sell | 2,608 | $69.37 | $180.9K | 0 |
| Jul 16, 2025↗ | Stamoulis Christiana | EVP & Chief Financial Officer | Sell | 2,852 | $69.10 | $197.1K | 0 |
| Jul 16, 2025↗ | Stein Steven H | EVP & Chief Medical Officer | Sell | 18,103 | $68.58 | $1.24M | 0 |
| Jul 16, 2025↗ | SWAIN PAULA J | EVP, Human Resources | Sell | 1,007 | $69.01 | $69.5K | 0 |
| Jul 16, 2025↗ | Tray Thomas | Principal Accounting Officer | Sell | 1,275 | $69.19 | $88.2K | 0 |
| Jul 7, 2025↗ | Denton Sheila A. | EVP & General Counsel | Sell | 599 | $68.61 | $41.1K | 0 |
| Jul 7, 2025↗ | Flannelly Barry P | EVP & General Manager US | Sell | 19,958 | $68.16 | $1.36M | 0 |
| Jul 7, 2025↗ | Hoppenot Herve | Special Advisor to the CEO | Sell | 42,769 | $68.17 | $2.92M | 0 |
| Jul 7, 2025↗ | Iyengar Vijay K | EVP, GMAPPS | Sell | 15,426 | $68.16 | $1.05M | 0 |
| Jul 7, 2025↗ | Stamoulis Christiana | EVP & Chief Financial Officer | Sell | 11,589 | $68.17 | $790.0K | 0 |
| Jul 7, 2025↗ | Stein Steven H | EVP & Chief Medical Officer | Sell | 12,714 | $68.17 | $866.7K | 0 |
| Jul 7, 2025↗ | SWAIN PAULA J | EVP, Human Resources | Sell | 6,285 | $68.17 | $428.4K | 0 |
| Jul 7, 2025↗ | Tray Thomas | Principal Accounting Officer | Sell | 897 | $68.17 | $61.1K | 0 |
| Jun 12, 2025↗ | Schaffert Susanne | Director | Sell | 849 | $70.07 | $59.5K | 0 |
| Jun 5, 2025↗ | Denton Sheila A. | EVP & General Counsel | Sell | 1,795 | $68.00 | $122.1K | 0 |
| Jun 3, 2025↗ | Tray Thomas | Principal Accounting Officer | Sell | 1,614 | $65.38 | $105.5K | 0 |
| Mar 27, 2025↗ | Trotta Matteo | EVP, GM, Dermatology US | Sell | 537 | $62.08 | $33.3K | 0 |
| Mar 18, 2025↗ | Flannelly Barry P | EVP & General Manager US | Sell | 19,807 | $67.69 | $1.34M | 0 |
| Mar 6, 2025↗ | Denton Sheila A. | EVP & General Counsel | Sell | 599 | $69.99 | $41.9K | 0 |
| Feb 28, 2025↗ | Denton Sheila A. | EVP & General Counsel | Sell | 14,069 | $74.07 | $1.04M | 0 |
INCY Insiders
Similar Stocks to INCY
VRTX
Vertex Pharmaceuticals Incorporated
$470.20-1.66%
$121.44B
REGN
Regeneron Pharmaceuticals, Inc.
$743.51-0.41%
$77.57B
ALNY
Alnylam Pharmaceuticals, Inc.
$313.45-1.19%
$42.07B
INSM
Insmed Incorporated
$139.06-0.33%
$30.07B
UTHR
United Therapeutics Corporation
$538.00+0.97%
$21.50B
RVMD
Revolution Medicines, Inc.
$95.44+0.39%
$20.10B
MRNA
Moderna, Inc.
$52.38-1.89%
$19.96B
ROIV
Roivant Sciences Ltd.
$28.14-1.44%
$19.80B